Continued circulation of mpox: an epidemiological and phylogenetic assessment, European Region, 2023 to 2024.

Autor: Vaughan AM; These authors contributed equally as first authors.; World Health Organization (WHO) Regional Office for Europe, Copenhagen, Denmark., Afzal M; These authors contributed equally as first authors.; European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden., Nannapaneni P; European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden., Leroy M; World Health Organization (WHO) Regional Office for Europe, Copenhagen, Denmark., Andrianou X; European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden., Pires J; World Health Organization (WHO) Regional Office for Europe, Copenhagen, Denmark., Funke S; European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden., Roman C; World Health Organization (WHO) Regional Office for Europe, Copenhagen, Denmark., Reyes-Uruena J; European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden., Aberle S; Medical University of Vienna, Centre for Virology, Vienna, Austria., Aristodimou A; Medical and Public Health Services, Nicosia, Cyprus., Aspelund G; Centre for Health Security and Communicable Disease Control, Directorate of Health, Reykjavik, Iceland., Bennet KF; United Kingdom Health Security Agency, London, United Kingdom., Bormane A; Center for Disease Prevention and Control of Latvia, Department of Infectious Diseases Risk Analysis and Prevention, Riga, Latvia., Caraglia A; Ministry of Health, Rome, Italy., Charles H; United Kingdom Health Security Agency, London, United Kingdom., Chazelle E; Santé publique France, the French National Public Health Agency, Saint-Maurice, France., Christova I; National Center of Infectious and Parasitic Diseases, Sofia, Bulgaria., Cohen O; Division of Epidemiology, Ministry of Health, Jerusalem, Israel., Constantinou C; Medical and Public Health Services, Nicosia, Cyprus., Couvreur S; Department of Epidemiology and Public Health, Sciensano, Brussels, Belgium., Diaz A; National Centre of Epidemiology, CIBER in Infectious Diseases (CIBERINFEC), Carlos III Health Institute, Madrid, Spain., Fabiánová K; National Institute of Public Health, Centre for Epidemiology and Microbiology, Department of Infectious Disease Epidemiology, Prague, Czechia., Ferraro F; Ministry of Health, Rome, Italy., Grenersen MP; Norwegian Institute of Public Health (NIPH), Oslo, Norway., Grilc E; NIJZ (NIPH), Centre for Communicable Diseases, Ljubljana, Slovenia., Hannila-Handelberg T; Finnish Institute for Health and Welfare, Helsinki, Finland., Hvass AK; Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark., Igoe D; HSE Public Health: National Health Protection Office, Dublin, Ireland., Jansen K; Department for Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany., Janță D; National Institute of Public Health, Bucharest, Romania., Kaoustou S; Directorate of Epidemiological Surveillance and Intervention for Communicable Diseases, National Public Health Organization, Marousi, Greece., Koch A; Department of Infectious Diseases, Rigshospitalet University Hospital, Copenhagen, Denmark.; Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark., Kosanovic Licina ML; Andrija Stampar Teaching Institute of Public Health, Zagreb, Croatia., Krumova S; National Center of Infectious and Parasitic Diseases, Sofia, Bulgaria., Labutin A; Swiss Federal Office of Public Health, Bern, Switzerland., Lachmann R; Department for Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany., Lecompte A; Department of Epidemiology and Public Health, Sciensano, Brussels, Belgium., Lefrançois R; Santé publique France, the French National Public Health Agency, Saint-Denis, France., Leitena V; Center for Disease Prevention and Control of Latvia, Department of Infectious Diseases Risk Analysis and Prevention, Riga, Latvia., Liitsola K; Finnish Institute for Health and Welfare, Helsinki, Finland., Mlinarić I; Croatian Institute of Public Health, Division for Epidemiology of Communicable Diseases, Zagreb, Croatia., Mor Z; School of Health Sciences, Ashkelon Academic College, Ashkelon, Israel.; Division of Epidemiology, Ministry of Health, Jerusalem, Israel., Neary M; HSE Health Protection Surveillance Centre, Dublin, Ireland., Novacek A; Austrian Agency for Health and Food Safety, Vienna, Austria., Øgle MW; Norwegian Institute of Public Health (NIPH), Oslo, Norway., Orlíková H; Department of Epidemiology and Biostatistics, Third Faculty of Medicine, Charles University, Prague, Czechia.; National Institute of Public Health, Centre for Epidemiology and Microbiology, Department of Infectious Disease Epidemiology, Prague, Czechia., Papadima K; Directorate of Epidemiological Surveillance and Intervention for Communicable Diseases, National Public Health Organization, Marousi, Greece., Rehn M; Public Health Agency of Sweden (PHAS), Solna, Sweden., Sadkowska-Todys M; National Institute of Public Health NIH - National Research Institute, Warsaw, Poland., Sîrbu A; National Institute of Public Health, Bucharest, Romania., Sondén K; Public Health Agency of Sweden (PHAS), Solna, Sweden., Suárez B; Coordinating Centre for Health Alerts and Emergencies (CCAES), Directorate General of Public Health, Ministry of Health, Madrid, Spain., Thordardottir M; Centre for Health Security and Communicable Disease Control, Directorate of Health, Reykjavik, Iceland., Vasconcelos P; Public Health Emergency Centre, Directorate-General of Health (DGS), Lisbon, Portugal., Vieira Martins J; Directorate of Information and Analysis, Directorate-General of Health, Lisbon, Portugal., Zakrzewska K; National Institute of Public Health NIH - National Research Institute, Warsaw, Poland., Widdowson MA; These authors contributed equally as last authors.; World Health Organization (WHO) Regional Office for Europe, Copenhagen, Denmark., Gossner CM; These authors contributed equally as last authors.; European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
Jazyk: angličtina
Zdroj: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin [Euro Surveill] 2024 Jul; Vol. 29 (27).
DOI: 10.2807/1560-7917.ES.2024.29.27.2400330
Abstrakt: During the summer of 2023, the European Region experienced a limited resurgence of mpox cases following the substantial outbreak in 2022. This increase was characterised by asynchronous and bimodal increases, with countries experiencing peaks at different times. The demographic profile of cases during the resurgence was largely consistent with those reported previously. All available sequences from the European Region belonged to clade IIb. Sustained efforts are crucial to control and eventually eliminate mpox in the European Region.
Databáze: MEDLINE